Drug delivery to the brain represents one of the most important challenges in the field of nanomedicine, as the study and planning of nanocarriers able to cross the blood brain barrier are topics at the cutting edge of technology and innovation. In this review, we analyze the interventions and progresses in the field, by analyzing the choice of the polymer, of the ligands and the main relevant in vivo and in vitro experiments. A critical overview of these aspects will help in better understanding the status of nanomedicine in the application to central nervous system pathologies along with the future directions.
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of bloodebrain barrier crossing and trafficking into the central nervous system.
Musumeci T;Claudia Carbone;Rosario Pignatello;Giovanni Puglisi.
2016-01-01
Abstract
Drug delivery to the brain represents one of the most important challenges in the field of nanomedicine, as the study and planning of nanocarriers able to cross the blood brain barrier are topics at the cutting edge of technology and innovation. In this review, we analyze the interventions and progresses in the field, by analyzing the choice of the polymer, of the ligands and the main relevant in vivo and in vitro experiments. A critical overview of these aspects will help in better understanding the status of nanomedicine in the application to central nervous system pathologies along with the future directions.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
27_Tosi_Musumeci_review_2015.pdf
solo gestori archivio
Licenza:
Non specificato
Dimensione
484.26 kB
Formato
Adobe PDF
|
484.26 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.